Paul Pierce, MD
Cardiovascular Disease · Vicksburg, MSNPI 1821005265
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 770 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations.
Across 770 payments — averaging $25.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$4K
- Inari Medical, Inc.$2K
- Boston Scientific$2K
- Merck$1K
- Stryker$1K
- Abbott$936
- plus $8K from 36 others
What the payments were for
- Travel & lodging$1,7139%
- Food & beverage$17,58891%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 121 | $4,495 |
| Inari Medical, Inc. | 112 | $2,126 |
| Boston Scientific | 72 | $1,634 |
| Merck | 39 | $1,339 |
| Stryker | 37 | $1,083 |
| Abbott | 51 | $936 |
| Endologix LLC | 5 | $889 |
| Shockwave Medical, Inc | 38 | $829 |
| Bard Peripheral Vascular, Inc. | 31 | $784 |
| Novartis | 48 | $770 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 46 | $769 |
| Boehringer Ingelheim | 23 | $398 |
| Amgen | 21 | $301 |
| Johnson & Johnson | 18 | $276 |
| E.r. Squibb & Sons, L.L.C. | 11 | $268 |
| AstraZeneca | 16 | $261 |
| Siemens Medical Solutions USA, Inc. | 5 | $245 |
| Pfizer | 14 | $232 |
| Mentor Worldwide LLC | 4 | $205 |
| Angiodynamics, Inc. | 3 | $176 |
| Terumo Medical Corporation | 4 | $150 |
| Bayer | 6 | $137 |
| Cook Medical LLC | 6 | $129 |
| Scpharmaceuticals Inc. | 5 | $108 |
| Imperative Care, Inc | 3 | $105 |
| GE HealthCare | 1 | $83 |
| Cvrx, Inc. | 4 | $80 |
| Kowa Pharmaceuticals America, Inc. | 6 | $78 |
| Medtronic | 3 | $65 |
| Kestra Medical Technology Services, Inc. | 2 | $57 |
| Teleflex LLC | 2 | $41 |
| Philips North America LLC | 2 | $37 |
| GSK | 2 | $35 |
| BD | 1 | $29 |
| Novo Nordisk | 1 | $28 |
| Biotronik Inc. | 1 | $24 |
| Itamar Medical Inc | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| AbbVie | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Penumbra, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$1,485
- FLOWTRIEVER CATHETER, S$948
- CT THROMBECTOMY SYSTEM KIT$948
- Torus Stent Graft System$840
- ENDOCROSS Device$840
- VERQUVO$672
- ARTIX MT$160
- Lutonix Drug Coated Balloon$136
- Auryon Laser System 100-120 Vac$124
- VENOVO$115
- Cios Alpha$107
- CAMZYOS$102
- AVVIGO Guidance System$101
How this compares
$19,327 in reported general payments places this provider in the 85th percentile of 144 cardiovascular disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 390 | $302,289 |
| EliquisApixaban | 325 | $248,667 |
| JardianceEmpagliflozin | 222 | $203,686 |
| EntrestoSacubitril/Valsartan | 138 | $157,339 |
| BrilintaTicagrelor | 188 | $117,404 |
| FarxigaDapagliflozin Propanediol | 98 | $82,919 |
| Repatha SureclickEvolocumab | 24 | $32,537 |
| Sildenafil Citrate | 45 | $8,417 |
| Metoprolol Succinate | 669 | $6,268 |
| ClopidogrelClopidogrel Bisulfate | 725 | $5,595 |
| Propafenone Hcl | 63 | $3,546 |
| Ranolazine ErRanolazine | 59 | $3,313 |
| Atorvastatin Calcium | 400 | $2,866 |
| Potassium Chloride | 170 | $2,287 |
| Nebivolol Hcl | 72 | $2,256 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $276 | $302,289390 claims |
| PfizerEliquis | $232 | $248,667325 claims |
| Boehringer IngelheimJardiance | $398 | $203,686222 claims |
| AstraZenecaBrilinta, Farxiga | $261 | $200,323286 claims |
| NovartisEntresto | $770 | $157,339138 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 144 cardiovascular disease providers in Mississippi.
Other cardiovascular disease in Vicksburg
- Murray WhitakerVicksburg$6K
- Dharmesh PatelSouthaven$1.5M
- Barry BertoletTupelo$469K
- Donny StokesJackson$207K
- Mahmoud ZayedPascagoula$103K
- James BenslerJackson$64K
- Michael HallJackson$54K
- Hugo QuintanaPascagoula$48K
- Ediz TasanPascagoula$42K
- Lawrence LeaderHattiesburg$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.